REGIS NU 641 CLINICAL ADV PHARMACOLOGY
FINAL EXAM QUESTIONS AND ANSWERS FROM
ACTUAL EXAM 2023
1. When cadministering cthe cdrug csenna cto ca cpatient, ca chealth ccare cprovider cmust cinform cthe
cpatient cof cwhich cof cthe cfollowing
a. This cdrug cis cintended cto clower cblood cpressure cand cis cbest cused cin ccombination
with cother cantihypertensives
b. This cdrug cis cnot cintended cfor clong cterm cuse
c. The cpatient cmust climit chis/her cfiber cintake
d. Advise cpatient cto cchange cpositions cslowly cto climit cthe crisk cof
corthostatic chypotension
,2. When cgiving cdigoxin c(Lanoxin) cto ca cpatient, cthe chealth ccare cprovider cnotices
cvarious csigns cand csymptoms cof can coverdose. cThe chealth ccare cprovider cknows
cto cgive cwhich cof cthe cfollowing cto creverse cdigoxin ctoxicity
a. Naloxone
b. Vitamin cK
c. Digibind
d. Fluemanzil
3. While cproviding can cAngiotensin-converting cenzyme c(ACE) cinhibitor, cthe cpatient
casks cwhat cthe caction cof cthe cdrug cis. cAs ca chealth ccare cprovider, cyou cexplain
cthat cthe caction cof can ACE
To clower cblood cpressure cby cblocking cthe cconversion cof inhibitor
is cangiotensin cI c
a. to vasoconstrictor c angiotensin c II
b. To cinhibit creabsorption cof csodium cback cinto cthe cbody, cultimately
cincreasing curine coutput cand clowering cblood cpressure
c. To cdecrease cheart crate cand cblood cpressure cby ccompeting cwith
cBeta1 cand cBeta2 creceptors cin cthe cheart cand clungs
d. To clower cblood cglucose cby cstimulating cthe crelease cof cinsulin
4. Which cof cthe cfollowing ctypes cof cinsulin cis c“long-acting”?
a. Lispro c(Humalog)
b. NPH c(Humulin cN)
c. Regular cinsulin c(Humulin
R) cd. cGlargine c(Lantus)
1. What cis cthe ctherapeutic cuse cof cmetformin?
A. Lower cblood cpressure.
B. To cdiminish cseizure cactivity.
C. The cmaintenance cof ca cperson’s cblood cglucose.
, D. Increase cheart crate cand cdecrease cgastrointestinal csecretions.
Movement cof cdrug cfrom csite cof cadministration cto cvarious ctissues cof cthe cbody.
1. What cis cthe ccorrect cdefinition cfor cabsorption cof ca cdrug? cA.
B. c Describes cthe cabsorption, cdistribution, cmetabolism c& cexcretion cof cdrugs.
C. c These ctypes cof cdrugs ccan cbe ctaken cover cthe ccounter.
D. c This caddresses chow cvarious cdrugs caffect cdifferent cforms cof cthe cbody.
2. What cdo you cassess cfor cin ca cpatient cwho cis
A. cSuicidal con cValproate? cSelect call cthat
cthoughts capply.
B. cMonitor cfor cseizures.
cBipolar cdisorder. c
D. cMigraines.
3. What
cis You cmust climit ccertain ctypes cof cfood cor cconcurrent cadministration cof
ctrue ccertain
cabou
types of cdrugs.
c
t
cfood
and cdrug cprecautions? cSelect call cthat capply. cA.
B.
C. Precautions cmay crequire climiting ccertain ctypes cof cfood cor cconcurring cdrugs
c c
rather than crestricting cthe cdrug .
citself
D. c When cone cdrug cchanges cthe cway, canother cdrug caffects cthat cdrug.
1. ACE cInhibitors care cused cin cthe ctreatment cof call cEXCEPT:
a. Hypertension
b. Heart cFailure
c. Hypotension
d. Diabetic cnephropathy
2. Which cof the cfollowing cis cused cto ctreat
cmigraine c headaches? c a. cBeta-blockers
b. Cholinesterase c Inhibitors
c. ACE cinhibitors
d. Anti-epileptic cdrugs c(AEDs)
3. When cadministering ca cSerotonin cAntagonist cit cis cimportant cto
cmonitor cfor
a. Intake cand coutput
b. Mental cstatus cchanges
, c. Respiratory crate
d. Anorexia
FINAL EXAM QUESTIONS AND ANSWERS FROM
ACTUAL EXAM 2023
1. When cadministering cthe cdrug csenna cto ca cpatient, ca chealth ccare cprovider cmust cinform cthe
cpatient cof cwhich cof cthe cfollowing
a. This cdrug cis cintended cto clower cblood cpressure cand cis cbest cused cin ccombination
with cother cantihypertensives
b. This cdrug cis cnot cintended cfor clong cterm cuse
c. The cpatient cmust climit chis/her cfiber cintake
d. Advise cpatient cto cchange cpositions cslowly cto climit cthe crisk cof
corthostatic chypotension
,2. When cgiving cdigoxin c(Lanoxin) cto ca cpatient, cthe chealth ccare cprovider cnotices
cvarious csigns cand csymptoms cof can coverdose. cThe chealth ccare cprovider cknows
cto cgive cwhich cof cthe cfollowing cto creverse cdigoxin ctoxicity
a. Naloxone
b. Vitamin cK
c. Digibind
d. Fluemanzil
3. While cproviding can cAngiotensin-converting cenzyme c(ACE) cinhibitor, cthe cpatient
casks cwhat cthe caction cof cthe cdrug cis. cAs ca chealth ccare cprovider, cyou cexplain
cthat cthe caction cof can ACE
To clower cblood cpressure cby cblocking cthe cconversion cof inhibitor
is cangiotensin cI c
a. to vasoconstrictor c angiotensin c II
b. To cinhibit creabsorption cof csodium cback cinto cthe cbody, cultimately
cincreasing curine coutput cand clowering cblood cpressure
c. To cdecrease cheart crate cand cblood cpressure cby ccompeting cwith
cBeta1 cand cBeta2 creceptors cin cthe cheart cand clungs
d. To clower cblood cglucose cby cstimulating cthe crelease cof cinsulin
4. Which cof cthe cfollowing ctypes cof cinsulin cis c“long-acting”?
a. Lispro c(Humalog)
b. NPH c(Humulin cN)
c. Regular cinsulin c(Humulin
R) cd. cGlargine c(Lantus)
1. What cis cthe ctherapeutic cuse cof cmetformin?
A. Lower cblood cpressure.
B. To cdiminish cseizure cactivity.
C. The cmaintenance cof ca cperson’s cblood cglucose.
, D. Increase cheart crate cand cdecrease cgastrointestinal csecretions.
Movement cof cdrug cfrom csite cof cadministration cto cvarious ctissues cof cthe cbody.
1. What cis cthe ccorrect cdefinition cfor cabsorption cof ca cdrug? cA.
B. c Describes cthe cabsorption, cdistribution, cmetabolism c& cexcretion cof cdrugs.
C. c These ctypes cof cdrugs ccan cbe ctaken cover cthe ccounter.
D. c This caddresses chow cvarious cdrugs caffect cdifferent cforms cof cthe cbody.
2. What cdo you cassess cfor cin ca cpatient cwho cis
A. cSuicidal con cValproate? cSelect call cthat
cthoughts capply.
B. cMonitor cfor cseizures.
cBipolar cdisorder. c
D. cMigraines.
3. What
cis You cmust climit ccertain ctypes cof cfood cor cconcurrent cadministration cof
ctrue ccertain
cabou
types of cdrugs.
c
t
cfood
and cdrug cprecautions? cSelect call cthat capply. cA.
B.
C. Precautions cmay crequire climiting ccertain ctypes cof cfood cor cconcurring cdrugs
c c
rather than crestricting cthe cdrug .
citself
D. c When cone cdrug cchanges cthe cway, canother cdrug caffects cthat cdrug.
1. ACE cInhibitors care cused cin cthe ctreatment cof call cEXCEPT:
a. Hypertension
b. Heart cFailure
c. Hypotension
d. Diabetic cnephropathy
2. Which cof the cfollowing cis cused cto ctreat
cmigraine c headaches? c a. cBeta-blockers
b. Cholinesterase c Inhibitors
c. ACE cinhibitors
d. Anti-epileptic cdrugs c(AEDs)
3. When cadministering ca cSerotonin cAntagonist cit cis cimportant cto
cmonitor cfor
a. Intake cand coutput
b. Mental cstatus cchanges
, c. Respiratory crate
d. Anorexia
